<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="topic" /><meta name="keywords" content="Vaccination: schedule; Immunisation: schedule" /><meta name="IX" content="Vaccination: schedule; Immunisation: schedule" /><title>Immunisation schedule: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="38311.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="38311.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=38311.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2081.htm">14 Immunological products and vaccines</a> &gt; <a href="6451.htm">14.1 Active immunity</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="6451.htm" title="Previous: 14.1 Active immunity">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="104920.htm" title="Next: High-risk groups">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>British National Formulary (59)</h3></li><li><a href="6451.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">14.1 Active immunity</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 14 Immunological products and vaccines</p></div></li><li><a href="6457.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">BCG vaccines</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 14 Immunological products and vaccines &gt; 14.4 Vaccines and antisera</p></div></li><li><a href="6467.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Diphtheria vaccines</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 14 Immunological products and vaccines &gt; 14.4 Vaccines and antisera</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22vaccination%22%22immunisation%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (59)</a></li></ul><ul><li><h3>BNF for Children (42)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/6451.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">14.1 Active immunity</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 14 Immunological products and vaccines</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/38311.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Immunisation schedule</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 14 Immunological products and vaccines &gt; 14.1 Active immunity</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/6452.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">14.2 Passive immunity</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 14 Immunological products and vaccines</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22vaccination%22%22immunisation%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (42)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/17192-a3-1-q.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fever and hyperthermia</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Analgesics Anti-inflammatory Drugs and Antipyretics &gt; Increased Body Temperature</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/3892-a1-c.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Introduction</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Vaccines Immunoglobulins and Antisera</p></div></li></ul><ul><li><h3>Rules &amp; Guidance for Pharmaceutical Manufacturers &amp; Distributors</h3></li><li><a href="http://www.medicinescomplete.com/mc/orange/2009/c02sec1084.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Personnel</a><div class="breadcrumb"><p><strong>Rules &amp; Guidance for Pharmaceutical Manufacturers &amp; Distributors</strong> &gt; II  GUIDANCE ON GOOD MANUFACTURING PRACTICE (GMP) &gt; 2  EU Guidance on Good Manufacturing
Practice &gt; PART I:  Basic Requirements for Medicinal
Products &gt; ANNEX 2  MANUFACTURE OF BIOLOGICAL MEDICINAL PRODUCTS FOR HUMAN USE</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_38311">Immunisation schedule</h1><?highlighter on?><div id="pC" class="jN"><div class="cAR"><p class="cAX">Vaccines
for the childhood immunisation schedule should be obtained from <b>local health organisations</b> or <b>from ImmForm</b> (<a href="https://www.immform.dh.gov.uk/" title="external link">www.immform.dh.gov.uk</a>)—not to be prescribed on FP10 (HS21 in Northern Ireland; GP10 in
Scotland; WP10 in Wales).</p></div><div id="_201730"><div class="cN"><h3 class="cBP">Preterm birth</h3><p>Babies born preterm should receive all routine immunisations
based on their actual date of birth. The risk of apnoea following
vaccination is increased in preterm babies, particularly in those
born at or before 28 weeks postmenstrual age. If babies at risk of
apnoea are in hospital at the time of their first immunisation, they
should be monitored for 48 hours after immunisation. If a baby develops
apnoea, bradycardia, or desaturation after the first immunisation,
the second immunisation should also be given in hospital with similar
monitoring. Seroconversion may be unreliable in babies born earlier
than 28 weeks’ gestation or in babies treated with corticosteroids
for chronic lung disease; consideration should be given to testing
for antibodies against <span class="cAC">Haemophilus influenzae</span> (type b), meningococcal C, and hepatitis B after primary immunisation.</p></div></div><div class="cBM">Immunisation Schedule</div><table class="cBL" width="100%" cellspacing="0" cellpadding="8" border="0" summary="Immunisation Schedule"><thead><tr><th>When to immunise (for preterm infants—see note above)</th><th>Vaccine given and dose schedule (for details of dose, see under individual vaccines)</th></tr></thead><tbody><tr><td>Neonates at risk only</td><td><ul class="cBF"><li><p class="cQ"><b>BCG Vaccine </b><br />See section 14.4,
BCG Vaccines</p></li><li><p class="cQ"><b>Hepatitis B Vaccine</b><br />See section
14.4, Hepatitis B Vaccine</p></li></ul></td></tr><tr><td>2 months</td><td><ul class="cBF"><li><p class="cQ"><b>Diphtheria, Tetanus, Pertussis (Acellular, Component),
Poliomyelitis (Inactivated), and Haemophilus Type b Conjugate Vaccine
(Adsorbed) </b><br />First dose</p></li><li><p class="cQ"><b>Pneumococcal Polysaccharide Conjugate Vaccine
(Adsorbed)</b><br />First dose</p></li></ul></td></tr><tr><td>3 months</td><td><ul class="cBF"><li><p class="cQ"><b>Diphtheria, Tetanus, Pertussis (Acellular, Component),
Poliomyelitis (Inactivated), and Haemophilus Type b Conjugate Vaccine
(Adsorbed)</b><br />Second dose</p></li><li><p class="cQ"><b>Meningococcal Group C Conjugate Vaccine</b><br />First dose</p></li></ul></td></tr><tr><td>4 months</td><td><ul class="cBF"><li><p class="cQ"><b>Diphtheria, Tetanus, Pertussis (Acellular, Component),
Poliomyelitis (Inactivated), and Haemophilus Type b Conjugate Vaccine
(Adsorbed)</b><br />Third dose</p></li><li><p class="cQ"><b>Meningococcal Group C Conjugate Vaccine</b><br />Second dose</p></li><li><p class="cQ"><b>Pneumococcal Polysaccharide Conjugate Vaccine
(Adsorbed)</b><br />Second dose</p></li></ul></td></tr><tr><td>12–13 months</td><td><ul class="cBF"><li><p class="cQ"><b>Measles, Mumps and Rubella Vaccine, Live (MMR) </b><br />First dose</p></li><li><p class="cQ"><b>Pneumococcal Polysaccharide Conjugate Vaccine
(Adsorbed) </b><br />Single booster dose</p></li><li><p class="cQ"><b>Haemophilus Type b Conjugate Vaccine and Meningococcal
Group C Conjugate Vaccine</b></p><p class="cQ">Single booster dose</p></li></ul></td></tr><tr><td>Between 3 years and
4 months, and 5 years</td><td><ul class="cBF"><li><p class="cQ"><b>Adsorbed Diphtheria [low dose], Tetanus, Pertussis
(Acellular, Component) and Poliomyelitis (Inactivated) Vaccine </b></p><p class="cQ"><i>or </i></p><p class="cQ"><b>Adsorbed Diphtheria, Tetanus, Pertussis (Acellular,
Component) and Poliomyelitis (Inactivated) Vaccine</b></p><p class="cQ">Single booster dose</p><p class="cQ"><b>Note:</b> Preferably allow interval of at least
3 years after completing primary course</p></li><li><p class="cQ"><b>Measles, Mumps and Rubella Vaccine, Live (MMR) </b></p><p class="cQ">Second dose</p></li></ul></td></tr><tr><td>12–13 years  (females
only)</td><td><ul class="cBF"><li><p class="cQ"><b>Human Papilloma Virus Vaccine </b><br />3 doses; second dose 1–2 months, and third dose 6 months after first
dose<sup class="footnote"><a title="Go to footnote" href="38311.htm#footnote200826">(1)</a></sup></p></li></ul></td></tr><tr><td>13–18 years</td><td><ul class="cBF"><li><p class="cQ"><b>Adsorbed Diphtheria [low dose], Tetanus, and Poliomyelitis (Inactivated) Vaccine </b><br />Single
booster dose</p></li></ul></td></tr><tr><td>During adult life,
women of child-bearing age susceptible to rubella</td><td><ul class="cBF"><li><p class="cQ"><b>Measles, Mumps and Rubella Vaccine, Live (MMR) </b><br />Women of child-bearing age who have not received 2 doses
of a rubella-containing vaccine or who do not have a positive antibody
test for rubella should be offered rubella immunisation (using the
MMR vaccine)—exclude pregnancy before immunisation, but see also section
14.4, Measles, Mumps and Rubella Vaccine</p></li></ul></td></tr><tr><td>During adult life,
if not previously immunised</td><td><ul class="cBF"><li><p class="cQ"><b>Adsorbed Diphtheria [low dose], Tetanus, and Poliomyelitis
(Inactivated) Vaccine</b><br />3 doses at intervals of 1
month</p><p class="cQ">Booster dose at least 1 year after primary course and again
5–10 years later</p></li></ul></td></tr></tbody></table></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="104920.htm" title="High-risk groups">High-risk groups</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="6451.htm">Previous: 14.1 Active immunity</a> | <a class="top" href="38311.htm#">Top</a> | <a accesskey="]" href="104920.htm">Next: High-risk groups</a> ►</div><div class="cF"><div class="footnote" id="footnote200826"><sup>(1)</sup>The two human papilloma virus vaccines are not interchangeable
and one vaccine product should be used for the entire course; however
for individuals with previous incomplete vaccination with <span class="cZ">Gardasil</span>® who are eligible for HPV vaccination under the
national programme, <span class="cZ">Cervarix</span>® can be used (until
September 2012) to complete the vaccination course if necessary; the
individual must be informed that <span class="cZ">Cervarix</span>® does
not protect against genital warts.</div></div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>